The Cabinet of Ministers approved a bill on updating the strategy, which provides for the restoration of war-damaged territories and the integration of EU requirements.
The Kyiv Commercial Court will hear a lawsuit on 16 November seeking to invalidate an investment agreement for the Main Astronomical Observatory site. The investor is LLC "Freds Resorts", whose shares are held by Vladislava Molchanova's sons.
Ukrainian President explained why a new head of the Office of the Prosecutor General has not yet been appointed and responded to accusations made against him by the former head of the department.
Desnyansky District Court is hearing the prosecution's case against Vasyl Bilohura. He is accused of inflating construction material costs during the reconstruction of a gymnasium funded by Swiss grants.
Analytics show that 1,399 documents submitted by 1,012 individuals working for the SBU are hidden from public access. The record is for 2023.
The new Deputy Minister of Digital Transformation, Valeriia Koval, holds a degree in political science and has extensive experience in the digitalisation sector.
Anna Prokop described how two men and a woman surrounded a young Ukrainian in a Żabka store, insulting him and threatening to return after his shift.
A company uniting marine drone experts and investors has appeared in Bucha. Analysis of the ownership structure revealed links to the "Falkor" fund and a discussion regarding the identity of one of the beneficiaries.
American scientists from the University of Pennsylvania have made a significant step in the fight against the herpes virus — they have developed chewing gum capable of reducing the risk of infection by almost 95%. According to the researchers, this could be a real breakthrough in the field of antiviral prevention.
The key ingredient is a special antiviral protein extracted from the beans of the lablab plant. It acts as a trap, binding to viral particles and blocking their entry into cells. Protection is maintained even during close contact — whether through kisses or the coughing of an infected person.
In addition to herpes, the gum shows high efficacy against other viruses — including dangerous strains of bird flu. This opens up prospects for the creation of a new class of protective agents that are simple and convenient for everyday use.
The scientific team is already preparing for clinical trials and hopes to bring the product to market in the coming years. If the development receives approval, the world will be able to take another step towards controlling viruses that have long remained beyond the reach of medicine.
Comments
No comments yet. Be the first!